Submission Deadline: Tuesday, June 10, 2025, 5:00 PM JST
| 1 | AIS |
|---|---|
| 2 | Cerebral AN |
| 3 | Vasospasm |
| 4 | Carotid and intracranial artery stenosis |
| 5 | Dural AVF and AVM |
| 6 | Spinal cord shunt diseases |
| 7 | Dissection |
| 8 | Pediatric and Congenital Diseases |
| 9 | Head, neck and facial diseases |
| 10 | Intracranial tumor |
| 11 | Subdural hematoma |
| 12 | Traumatic insury |
| 13 | Inflammatory diseases |
| 14 | Complications of treatment |
| 15 | Anatomy, Development and Physiology |
|---|---|
| 16 | Diagnostic Imaging and Angiography |
| 17 | Medical support system and AI |
| 18 | Divices |
| 19 | Transradial approach and other vascular access |
| 20 | Perioperative management |
| 21 | Medical team and education |
| 22 | Basic research |
| 23 | Technical tips |
| 24 | Technicians |
| 25 | Nurses |
| 26 | Medical staff, other |
| 27 | Other |
- An abstract must have a short, specific title (containing no abbreviations or inflammatory language) that indicates the nature of the investigation.
- Abstracts may have the following identifiable sections: Introduction, Hypothesis, Methods, Results and Conclusions.
- Abstracts should be limited to approximately 300 words, excluding the title and authors.
Spaces do not count as characters. Figures or tables should not be included in the abstract.
- The submitting author is designated as the primary and presenting author.
- Please review the author block carefully. Additions or deletions of author names are not permitted after the submission deadline.
Congress Secretariat for JSNET2025
c/o Congrès Inc.
E-mail: jsnet2025@congre.co.jp
©2024 The 41st Annual Meeting of the Japanese Society for Neuroendovascular Therapy